These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 34175645)

  • 41. Covid-19 associated Guillain-Barré syndrome: A series of a relatively uncommon neurological complication.
    Chakraborty U; Hati A; Chandra A
    Diabetes Metab Syndr; 2021; 15(6):102326. PubMed ID: 34731822
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Guillain-Barre Syndrome Associated With COVID-19 Pneumonia-The First Documented Case in a U.S. Military Intensive Care Unit.
    Yiu AC; Hussain A; Okonkwo UA; Villacorta-Lyew R; McMahon MJ; Blattner M
    Mil Med; 2023 Mar; 188(3-4):e852-e856. PubMed ID: 33881526
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Guillain-Barré Syndrome after Novel Coronavirus Disease 2019.
    Yakoby J; Litvak I; Yu E
    J Emerg Med; 2021 Oct; 61(4):e67-e70. PubMed ID: 34103203
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Guillain-Barré Syndrome as a Neurological Complication of Novel COVID-19 Infection: A Case Report and Review of the Literature.
    Paybast S; Gorji R; Mavandadi S
    Neurologist; 2020 Jul; 25(4):101-103. PubMed ID: 32618839
    [TBL] [Abstract][Full Text] [Related]  

  • 45. COVID-19-associated Guillain-Barré syndrome: The early pandemic experience.
    Caress JB; Castoro RJ; Simmons Z; Scelsa SN; Lewis RA; Ahlawat A; Narayanaswami P
    Muscle Nerve; 2020 Oct; 62(4):485-491. PubMed ID: 32678460
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Guillain-Barré syndrome after COVID-19 in Japan.
    Hirayama T; Hongo Y; Kaida K; Kano O
    BMJ Case Rep; 2020 Oct; 13(10):. PubMed ID: 33122241
    [TBL] [Abstract][Full Text] [Related]  

  • 47. SARS-CoV-2-associated Guillain-Barré syndrome in four patients: what do we know about pathophysiology?
    Guilmot A; Maldonado Slootjes S; Bissay V; Dubuisson N; de Broglie C; Gille M
    Acta Neurol Belg; 2022 Jun; 122(3):703-707. PubMed ID: 34476752
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Guillain-Barré syndrome associated with SARS-CoV-2 infection. A systematic review.
    De Sanctis P; Doneddu PE; Viganò L; Selmi C; Nobile-Orazio E
    Eur J Neurol; 2020 Nov; 27(11):2361-2370. PubMed ID: 32757404
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Post-COVID-19 Guillain-Barré Syndrome: A case report from Oman.
    Al-Zadjali MM; Al Shibli E; Al Maskari M; Gujjar AR; Al Asmi A
    Sultan Qaboos Univ Med J; 2022 Aug; 22(3):409-412. PubMed ID: 36072070
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Guillain-Barre syndrome in a 7-month-old boy successfully applied plasma exchange.
    Akarcan SE; İşgüder R; Yılmaz Ü; Ayhan Y; Ceylan G; Ağın H
    Transfus Apher Sci; 2016 Feb; 54(1):139-43. PubMed ID: 26803348
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Guillain-Barré syndrome associated with SARS-CoV-2 infection: A systematic review and individual participant data meta-analysis.
    Hasan I; Saif-Ur-Rahman KM; Hayat S; Papri N; Jahan I; Azam R; Ara G; Islam Z
    J Peripher Nerv Syst; 2020 Dec; 25(4):335-343. PubMed ID: 33112450
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Experience of treatment in critical Guillain-Barre Syndrome case after COVID-19 vaccination.
    Zhu C; Wang H; Zhang Y; Wang W; Wang J; Li W
    Int J Dev Neurosci; 2024 Jun; 84(4):342-348. PubMed ID: 38590219
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Guillain-Barré syndrome following thoracic spinal cord trauma.
    Scozzafava J; Jickling G; Jhamandas JH; Jacka MJ
    Can J Anaesth; 2008 Jul; 55(7):441-6. PubMed ID: 18591702
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Guillain-Barre syndrome associated to COVID-19 infection: a review of published case reports.
    Zuberbühler P; Conti ME; León-Cejas L; Maximiliano-González F; Bonardo P; Miquelini A; Halfon J; Martínez J; Gutiérrez MV; Reisin R
    Rev Neurol; 2021 Mar; 72(6):203-212. PubMed ID: 33710610
    [TBL] [Abstract][Full Text] [Related]  

  • 55. High risk and low prevalence diseases: Guillain-Barré syndrome.
    Madden J; Spadaro A; Koyfman A; Long B
    Am J Emerg Med; 2024 Jan; 75():90-97. PubMed ID: 37925758
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Guillain-Barré Syndrome Associated With Severe Acute Respiratory Syndrome Coronavirus 2 Detection and Coronavirus Disease 2019 in a Child.
    Khalifa M; Zakaria F; Ragab Y; Saad A; Bamaga A; Emad Y; Rasker JJ
    J Pediatric Infect Dis Soc; 2020 Sep; 9(4):510-513. PubMed ID: 32652520
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Guillain-Barré syndrome in patients with SARS-CoV-2 infection. Report of three cases.
    Cea G; Romero C; Aguilar S; Salinas R
    Rev Med Chil; 2021 Dec; 149(12):1812-1816. PubMed ID: 35735350
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Treatment related fluctuation and response to intravenous immunoglobulin therapy in post COVID-19 Guillain-Barre syndrome.
    Gupta S; Chandra A; Ray BK; Pandit A
    Diabetes Metab Syndr; 2021; 15(5):102246. PubMed ID: 34416468
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Plasma exchange for Guillain-Barré syndrome.
    Raphaël JC; Chevret S; Hughes RA; Annane D
    Cochrane Database Syst Rev; 2001; (2):CD001798. PubMed ID: 11406009
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Guillain-Barré Syndrome in India: population-based validation of the Brighton criteria.
    Mateen FJ; Cornblath DR; Jafari H; Shinohara RT; Khandit D; Ahuja B; Bahl S; Sutter RW
    Vaccine; 2011 Dec; 29(52):9697-701. PubMed ID: 22001121
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.